Psilocybin therapeutic use program established; protections for registered patients, registered suppliers, registered facilitators, and health care practitioners established; civil actions authorized; advisory committee established; and money appropriated.

This bill establishes a regulated therapeutic use program for psilocybin in Minnesota, allowing adults aged 21 and older with qualifying medical conditions to access the substance under medical supervision. The program requires patients to work with licensed health care practitioners and registered facilitators who oversee preparation, administration, and integration sessions. Key provisions include creating an advisory committee to guide program oversight, setting up registration requirements for patients, suppliers, and facilitators, and establishing civil penalties for violations. The legislation also appropriates funds for program implementation and creates a framework for data collection and public health monitoring.